10. …is as important as other recommended
vaccination
…is a vaccine I trust
…is supported by my doctor
…is a safe vaccine
…has demonstrated its efficacy
…is for girls only
…can also be administered to boys to prevent
diseases in boys
1.0 2.0 3.0 4.0
Total countries NOR (GP) DEN (All)
Perception of HPV Vaccination
Connection creates value 10
Q23: With regards to the vaccine against Human Papillomavirus/cervical cancer, to what extent would you say that you agree with each of the following statements ?
YOUNG MEN
BASE : Aware of HPV vaccine /Cervical cancer vaccine (623) (76) (109) (136) (159) (139)
11. After “burden” both Mothers and Young Men seem quite
favorable towards HPV vaccination in boys/ym
Connection creates value 11
Reactions to HPV vaccination of BOYS
BASE : All
SpainNorway Denmark PortugalTOTAL COUNTRIES
15
1
50 34
2
125 73
10
1
40 49 2 33 66
7
2
37 54
89% 84% 99% 91% 97%
(86) (177)(135) (143)(743)
Mothers
BOYS PC
Mothers
BOYS CC
YOUNG
MEN
12
2
51 34
(181) (176)(262) (141)(961)
3
1 26 71
8
2
41 49 2 35 64
7
1
41 51
90% 86 % 98 % 92 % 96 %
(152) (226)(120) (206)(910)
13
2 47 38152 51 32 191 51 29 10 54 36
5
2
50 42
83% 79% 90% 93% 85%
I am very unfavorable I am somewhat unfavorable
In spite of the fact that the Young men seem to feel little affected personally,
their attitude towards HPV vaccination in boys/ym is favorable
ST favorable
France
21
3 52 24
76 %
(202)
(201)
17
7 52 24
76 %
(200)
274 55 14
69%
12. 2.2
3.6
2.5
3.7
3.9
4.2
3.8
4.9
2.0
3.5
2.2
3.9
3.7
4.0
3.6
5.8
2.3
4.0
2.3
3.6
3.9
4.5
4.1
4.7
69
67
67
53
49
42
40
23
64
73
73
56
64
48
38
26
Drivers for vaccination
Connection creates value 12
Q37a: What could be the reasons that you want your son to get vaccinated against the Human Papillomavirus ?
Q37b: Could you please rank the reasons you selected in order of their importance for you ?
Mothers BOYS PC
Drivers 1/2
Spain MothersNorway Mothers
(66) (153)
Denmark Mothers
(131)
Portugal Mothers
(142)
TOTAL COUNTRIES
(652)
BASE Driver : Certainly or probably will get vaccinated or is already vaccinated BASE Rank : item quoted in Q37a
France Mothers
(160)
I welcome any protection
against cancers for my son
myself
Boys should have the
same access to protection
as girls
I want to avoid any risk of
the virus for my son
I want to avoid any risk of
transmission of the virus
to future or current
partners
I want to avoid genital
warts for my son
Getting my son vaccinated
will help to eradicate the
Human Papillomavirus
I think that the
vaccination offers the best
protection against Human
Papillomavirus
I trust the previous
success of girl’s
vaccination
79
73
66
59
50
52
37
33
65
59
58
44
44
36
37
18
68
65
70
58
36
43
48
21
71
68
68
51
59
35
37
21
PC
PC
CC
RANK
2.3
3.4
3.3
3.8
4.5
3.7
4.2
4.6
2.4
3.8
2.4
3.3
3.9
4.1
3.5
4.8
2.0
3.6
2.4
4.1
3.8
4.8
4.2
4.8
CC
CC
PC CC
13. In a typical month, how many new and restart
prescriptions or orders do you write for each of the
following agents?
140.0
140.0
140.0
140.0
140.0
Total
(n=630)
Mean Among Total Physicians
A/B/C indicates statistically significant difference @ 95% confidence level between countries
D/E indicates statistically significant difference @ 95% confidence level between specialties
US (A)
(n=321)
France (B)
(n=155)
Germany (C)
(n=154)
PCP (D)
(n=280)
Specialists (E)
(n=350)
Stub 1
Stub 1
Stub 1
Stub 1
Stub 1
QD
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
140.0
14. Top-2 Box Summary: Please use the following scale
to indicate how much you agree or disagree with the
following statements
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
Total
(n=630)
% Among Total Physicians
A/B/C indicates statistically significant difference @ 95% confidence level between countries
D/E indicates statistically significant difference @ 95% confidence level between specialties
US (A)
(n=321)
France (B)
(n=155)
Germany (C)
(n=154)
PCP (D)
(n=280)
Specialists (E)
(n=350)
Stub 1
Stub 1
Stub 1
Stub 1
Stub 1
Q5
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
50%
20%
20%
20%
20%
100%
40%
40%
40%
40%
Somewhat AgreeAgree Completely
15. Thinking about the next 100 patients you will see for
each of the patient types listed below, how will you
treat and/or
99%
37%
14%
20%
17%
20%
14%
99%
37%
17%
5% RRR (A)
(n=630)
Stub 1
Stub 1
Stub 1
Stub 1
Stub 1
Q6-6b
12% RRR (B)
(n=630)
20% RRR (C)
(n=630)
30% RRR (D)
(n=630)
99%
37%
14%
20%
17%
20%
14%
99%
37%
17%
99%
37%
14%
20%
17%
20%
14%
99%
37%
17%
99%
37%
14%
20%
17%
20%
14%
99%
37%
17%
0.9% Bleeding0.3% Bleeding
Mean % Among Physicians Asked
Letter indicates statistically significant difference @ 95% confidence level between sub groups
16. Segment segments segz size pie
Segment
15%
Segment
25%
Segment
25%
Segment
33%
Segment
2%
Breakdown of subgroup By
Segment (n=366)
1. Size of Segment
Segment
26%
Segment
39%
Segment
21%
Segment
12%
Segment
2%
Breakdown of subgroup By
Segment (n=182)
17. Provides effective
asthma control
Is associated with
enhanced compliance
Effective for
allergic rhinitis
Exhibits anti-
inflammatory properties
Prevents lung
remodeling
Reduces reliance on
PRN short-acting beta-
agonists
Provides nocturnal
control of asthma
Effect is evident on the
1st day of treatment
Provides real world
effectiveness
Works in a high
percentage of asthma
patients
Is appropriate switch
therapy for patients
uncontrolled on an
inhaled corticosteroid
Has a favorable side
effect profile
Is easy to use
Is effective for asthma
patients with allergic
triggers
Has a convenient
dosing regimen
Is cost effective for
the patient
Has favorable managed
care status
Is effective in blocking
leukotrienes
Is not associated with
systemic side effects
Prevents disease
progression
Is an appropriate first-
line monotherapy
maintenance medication
for asthma
Derived vs. Stated Importance Map:
StatedImportanceLowHigh
Derived Importance HighLow
Key DriversCost of Entry
Underlying Drivers
Least
Influential
18. % Among Total Physicians - Adult Market N=284/288
Importance: % of Physicians Who Find Attribute Most Influential When Prescribing for Asthma (Bradley-Terry Paired Comparison Analysis)
Imagery: % of Physicians Selecting Brand as Most Strongly Associated with Statement (Maximum Benefit Differentiation)
Letters denote statistically significant differences at the 95% confidence level between brands.
Number denote statistically significant differences at the 95% confidence level between waves
Provides Effective
Asthma Control
Importance Singulair® [A] Advair [B]
89%
80%
79%
76%
71%
70%
69%
82%
74%
75%
56%
74%
62%
55%
Alvesco [D]
Works In A High
Percentage Of Asthma
Patients
Provides Real World
Effectiveness
Exhibits
Anti-inflammatory
Properties
Reduces Reliance On
PRN Short-acting
Beta-agonists
Is Appropriate Switch
Therapy For Patients
Uncontrolled On An
Inhaled Corticosteroid
Is Not Associated With
Systemic Side Effects
8%
8%
16%
15%
8%
23%
86%
4%
6%
19%
8%
6%
25%
79%
90%
87%
81%
51%
88%
68%
5%
91%
87%
78%
56%
90%
70%
5%
1%
2%
2%
5%
1%
7%
3%
2%
2%
1%
10%
1%
5%
5%
Flovent [C]
1%
4%
2%
29%
3%
2%
7%
3%
5%
3%
26%
3%
1%
12%
CD ACD
D ACD AD
CD ACD
CD ACD
CD ACD C
BCD D
ACD
Importance / Imagery Charts
Q3/4
7/05
12/05
ACD
D ACD
8
CD ACD
ACD 8AD 8
D
ACD
CD ACD C
BCD 8BD
19. 0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Has a favorable side effect profile Prevents lung remodeling Is an appropriate first-line
monotherapy maintenance
medication for asthma
Exhibits anti-inflammatory
properties
-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
Importance Singulair Advair Flovent Alvesco Upper parity Lower Parity
Competitive Performance Diagnostic Charts
Extremely
Important
Extremely
Unimportant
83%
Competitor
Advantage
Parity
Zone
Singulair®
Advantage
Singulair®
Best Brand %
Q3,4
Among Total Adult (PCP/Allr/PUD)
Physicians.
12/05
7% 20% 8%
20. Competitive Performance Diagnostic Charts
4% 6% 5% 6% 6% 9%
Q5, 6
Among Total PED (GP/FPs/Allr/PED)
Physicians.
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Provides
effective asthma
control
Prevents
disease
progression
Exhibits anti-
inflammatory
properties
Reduces
reliance on PRN
short-acting
beta-agonists
Prevents lung
remodeling
Provides
nocturnal
control of
asthma
Is an
appropriate first-
line
monotherapy
maintenance
medication for
asthma
Indicated for
patients as
young as 12
months old
-1
-0.8
-0.6
-0.4
-0.2
0
0.2
0.4
0.6
0.8
1
Importance Singulair Advair Flovent
Alvesco Pulmicort Respules Upper parity Lower Parity
Extremely
Important
Extremely
Unimportant
Competitor
Advantage
Parity
Zone
Singulair®
Advantage
Singulair®
Best Brand % 28% 48%
12/05
21. PwC
Heat map (Q3 FY11)
21
September 2011
Scoring method
The chart above identifies systemic and isolated strengths and weaknesses in the survey results. The survey items used a five-point scale (Strongly Disagree,
Disagree, Neutral, and Agree, and Strongly Agree). The last two response options are combined to form one "Agree Score" which is the one reported in the
tables and charts. The higher the reported number, the more favorable the result. Unfavorable results are color-coded:
22. 22
48
42
34d
88d
47
83D
73
34
2
1
4
19
4
1
1d
9
1
1
FY’10
(B)
FY’11
(C)
Martini & Rossi Asti (M&R) and Korbel are still the category leaders in Brand awareness, but
M&R has lost awareness vs. two years ago. Korbel has also declined in brand awareness
over the past 2 years but not significantly. This more gradual decline may be tied to Korbel’s
large ad spend.
Brand Awareness Profiles
Q.1U/2U When you think of champagne or sparkling wine, what one brand first comes to mind? What other brands come to mind next?
Q.1A You may have mentioned some of these already, but please use the list below to indicate which of these brands of champagne or sparkling wine you are aware of.
#Less than 0.5%
NOTE: Competitive brands ranked on Est. Price Point
FY’09
(A)
Add chart to far right for FY12. Data should stay in same order
as stubs shown on slide on Left. Reduce chart widths as needed.
Data file: 104712compaa01 (hold off on Martini Net for now)
Unaided First Brand Mentions: Table 1-B6
Total Unaided Brand Mentions: Table 2-B6
Total Brand Awareness: Table 5-B6
Please update base
sizes for FY12
44
53B
27
82
15AB
19AB
45
74
69
32
2
2
2
23
1
4
1
1
6
1a
FY’12
(D)
53d
48
38D
83
42
85D
70
36
3
2
4
17
2
1
1
1
1
5
Martini/Martini & Rossi Asti
Ballatore
Yellow Tail Sparkling Wine
Freixenet
Korbel
Piper Sonoma
Mumm Napa
Chandon (Domaine
Chandon)
Moet & Chandon White
Star/Brut
Moet & Chandon Nectar
Veuve Clicquot Yellow
Label
48
49b
35d
86
22ABd
27ABd
43
80
68
33
1
2
5d
19
6a
1
7
Base: P12M C/SW Drinkers FY’09(204);
FY’10(262); FY11(203); FY12(201) Unaided 1st Brand Mentions Unaided Brand Mentions Total Brand Awareness
23. 23
Saw/Heard/Read Advertising – Top 10 Sources List
Consumers recollection of where they saw M&R advertising is unchanged from the past two
years.
Q.3A In which of these places have you seen, heard or read anything about champagne or sparkling wine recently? Among P12M C&SW Drinkers aware of Advertising
60%
45%B
40%D
33%
27%
29%
13%
15%
15%
13%
13%
16%
In A Store/In-Store Display
Magazines
TV
In A Bar/Club/Lounge
In A Restaurant
Talking To Someone Else
Radio
Posters, Billboards Or Other
Outdoor Ads
Duty Free Shop
Newspapers
The Internet Or Email Or Text
Message
Some Other Place
60%
32%
33%
31%
25%
30%
17%
20%
15%
13%d
10%
11%
M/M&R FY09
(A)
M/M&R FY10
(B)
M/M&R FY11
(C)
M/M&R FY12
(D)
Base: Aware of Advertising for Brand (119) (126) (89) (90)
60%
40%
34%
34%
24%
22%
20%d
19%
15%
15%d
13%
12%
Add chart to far right for FY12. Data should stay in same order
as stubs shown on slide on Left. Add base size for FY12.
Reduce chart widths as needed.
Data file: 104712compaa01
Table 7-B6
66%
36%
26%
27%
26%
29%
11%
12%
17%
7%
14%
9%
24. 24
Freixenet
2009 2010 2011 2012
A B C D
204 262 203 201
4 3 5 2
62 66 65 73
20 16 19 12
6 8 7 5
5 6 2
5
1 2 11 1
Chandon (Domaine Chandon)
2009 2010 2011 2012
A B C D
204 262 203 201
Korbel
2009 2010 2011 2012
A B C D
Base: Total 204 262 203 201
Martini/Martini & Rossi Asti
2009 2010 2011 2012
A B C D
Base: Total 204 262 203 201
7 3 3 6
58
53 57 55
23
27 22 25
9 8 10 6
3 6 6 61 2 11
6 6 8 5
8 13
19 23
37 36
33 29
18 14
13 14
22 23 18 24
3 4 4 24 5 5 2
0%
20%
40%
60%
80%
100%
Lover
Friend
Acquaintance
Familiar
Aware
Stranger
Rejecter
10 4 8 5
17
12
14 18
36
36 31 28
19
18 16 22
14
26 24 20
2 2 4 42 1 2 2
0%
20%
40%
60%
80%
100%
Lover
Friend
Acquaintance
Familiar
Aware
Stranger
Rejecter
Commitment
M&R has declined in acquaintances adding to strangers over the past two years. At the
same time Korbel has had a decline in Awares with an increase in strangers.
#- Less than .5%
Q.27 Consideration, Q.4, Consumption
Add Chart for FY12 to each section
(to the right of FY2012).
Data file: 104712compgmaa01
2009 – Table: 1-B309
2010 – Table: 1-B3012
2011 – Table: 1-B3015
2012 – Table: 1-B3018
25. 25
55%
48%
50%
58%
42%
52%
46%
40%
34%
30%
30%
38%
28%
M&R Brand Imagery
Over the course of the last two years, M&R has made significant headway on the majority of
brand imagery attributes including affinity (brand for me), quality and value.
Base: Aware of Brand and Randomly Selected: FY 2009 (104), FY 2010 (118), FY 2011 (99), FY 2012 (93)
Q.29 Using a scale from 5 to 1 where 5 means “Agree Completely” and 1 means “Disagree Completely”, please tell us how much you agree or disagree that each statement
describes the brands shown.
Martini/Martini & Rossi Asti
FY09
(A)
Martini/Martini & Rossi Asti
FY10
(B)
Is For Really Great Times With Friends
Is A Good Value For The Money
Is Good To Give As A Gift
Is Easy To Drink
Is Great For Home Entertaining
Not Only For Special Occasions
Is A Brand I'd Take To A Party
Smooth Tasting
Is A Brand For Me
An Informal Brand Of Champagne/Sparkling
Wine
Has A Sweeter Taste Than Other Brands
Is A High Quality Brand
Is For Fun Loving People
Is A Brand That Impresses Others
Truly Different From Other Brands
Shows Your Sense Of Style
Captures The Joy Of Living
Is Getting More Popular
Is For People Who Are Knowledgeable
About Sparkling Wine And Champagne
Is An Imported Italian Brand
Top 2 Box (Agree Completely/Somewhat) Martini/Martini & Rossi Asti
FY11
(C)
64%
60%a
64%A
65%
58%A
55%
59%AD
43%
51%A
44%A
34%
42%
42%A
68%AB
65%
65%A
63%a
62%AB
60%
60%AB
60%A
59%
58%d
55%Abd
54%A
51%AB
47%A
46%Ab
44%
41%AB
40%AB
39%a
37%AB
Add chart to far right for FY12. Add base
size for FY12. Reduce chart widths as
needed. Order statements by M&RFY11 –
use same statement order throughout rest
of imagery slides.
Data file: 104712compaa01
Table: 213-B6
Martini/Martini & Rossi Asti
FY12
(D)
67%AB
66%
66%A
69%A
72%AB
66%
69%AB
65%A
65%a
45%
42%
62%Ab
53%AB
56%Ab
49%AB
48%
48%AB
48%AB
39%
34%AB
26. 26
= Rating is significantly higher than Martini & Rossi Asti
= Rating is significantly lower than Martini & Rossi Asti
M&R Brand Imagery
Note: Ballatore & Mumm Napa were not asked at Imagery/Personality
Q.29 Using a scale from 5 to 1 where 5 means “Agree Completely” and 1 means “Disagree Completely”, please tell us how
much you agree or disagree that each statement describes the brands shown.
M&R is perceived to have a sweeter taste than other brands and is among the highest rated
on quality and a brand that impresses others.
Top 2 Box (Agree Completely/Somewhat)
Martini/
Martini &
Rossi Asti
Yellow Tail
Sparkling
Wine Freixenet Korbel
Piper
Sonoma
Chandon
(Domaine
Chandon)
Moet &
Chandon
White
Star/Brut
Moet &
Chandon
Nectar
Veuve
Clicquot
Yellow Label
$14.99 $8.99 $11.99 $13.99 $14.99 $19.99 $34.99 $44.99 $44.99
Base: Aware of Brand And Randomly Selected 93 58 41 92 18 53 76 73 33
Is For Really Great Times With Friends 67c 66c 49 68C 50 62 66c 70C 70c
Is A Good Value For The Money 66fGH 67fGH 54 70cFGH 50 49 50 45 55
Is Good To Give As A Gift 66 67 66 65 67 70 79aD 79AD 82aD
Is Easy To Drink 69 64 61 72 56 64 64 66 79ce
Is Great For Home Entertaining 72C 72c 54 72C 61 66 71c 70c 82Cf
Not Only For Special Occasions 66e 66 56 61 44 55 57 58 58
Is A Brand I'd Take To A Party 69E 64e 56 67E 39 58 75CEf 68E 82bCdEF
Smooth Tasting 65f 59 56 66F 56 49 63 68F 79BCeFg
Is A Brand For Me 65Cf 53 41 61C 61 49 64Cf 63C 73bCF
An Informal Brand Of Champagne/Sparkling Wine 45
72ACDEFGH
I
39 48gh 44 38 34 34 33
Has A Sweeter Taste Than Other Brands 42 45 29 34 33 30 43 44 39
Is A High Quality Brand 62Bd 36 59B 49 44 57B 76ABcDEF 82ABCDEF 85ABCDEF
Is For Fun Loving People 53c 71ACdEFg 37 58C 39 49 57C 59C 64Ce
Is A Brand That Impresses Others 56BF 34 46 45 56 38 71ABCDF 77ABCDeF 67BcDF
Truly Different From Other Brands 49cd 36 34 37 50 47 54BCD 55BCD 55bcd
Shows Your Sense Of Style 48 38 51 51 56 45 66ABdF 66ABdF 55
Captures The Joy Of Living 48 50 39 47 39 49 57c 56c 45
Is Getting More Popular 48 62aCDF 37 46 44 38 61CdF 51 58cf
Is For People Who Are Knowledgeable
About Sparkling Wine And Champagne
39 36 37 32 44 51D 66ABCDf 59ABCD 67ABCD
Is An Imported Italian Brand 34BD 17 29 16 28 25 25 26 27
Replace with FY12 data only. Order statements
same as previous slide. The Pert Group will add
the significance arrows later.
Data file: 104712compaa01
Table: 20-B1018
![© Synovate 2010 1
Opinion of overall
appearance of the tea
Opinion of overall color
of the tea
Opinion of clarity
of the tea
Q21a. Which of these phrases best describes your opinion of the overall appearance of the drink made of the green tea we sent you to try?
Q22. And which of these phrases best describes your opinion of the overall color of the drink?
Q24a. Which of the following phrases best describes your opinion of the clarity of the green tea you just tried?
A/B/C/D/E - Significantly higher than indicated group with 95% (upper case) and 90% (lower case) confidence level.
25%
26%
24%
24%
26%
24%
19%
25%
21%
22%
29%
28%
27%
38%
34%
34%
38%
27%
23%
25%
22%
27%
37%
33%
33%
33%
35%
31%
35%
32%
Excellent Very good
60%
55%
55%
62%
59%
T2B
BC
Appearance related measures – Unbranded
60%
55%
55%
62%
53%
60%
55%
55%
62%
55%
Lipton (N=219) [A] Bigelow (N=219) [B] Stash (N=219) [C] Salada (N=219) [D] Green (N=236) [E]
Comment
b
e](https://image.slidesharecdn.com/0cf992ed-dc6c-499f-9b25-ce8f4267ef30-160616184509/85/CHART-SAMPLE-1-320.jpg)
